When to refer patients for hospice care
What happens to patients once they reach the maximum benefit of traditional curative treatment? For many, hospice should be considered. A point on the…
Oncology
Genetic testing recommended for colorectal cancer patients
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients.…
Special report – War on Pain: Understanding pain and pain mechanisms
By Kevin T. Galloway, BSN, MHA; Chester C. Buckenmaier III, MD; and Rosemary C. Polomano, PhD, RN, FAAN Pain is a significant challenge both…
Lessons for more efficient research in healthcare settings
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about preventative health…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
Writing for good health
If you asked nurses how they reduce job stress, you probably wouldn’t expect them to reply, “By writing.” In fact, a recent research study…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
Shaving as a metaphor for nursing
Over the course of history, people have used metaphors to explain, contrive, reflect, and refute human phenomena. Health care (and all its challenges) has…
FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer…
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
When to refer patients for hospice care
What happens to patients once they reach the maximum benefit of traditional curative treatment? For many, hospice should be considered. A point…
Genetic testing recommended for colorectal cancer patients
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal…
Special report – War on Pain: Understanding pain and pain mechanisms
By Kevin T. Galloway, BSN, MHA; Chester C. Buckenmaier III, MD; and Rosemary C. Polomano, PhD, RN, FAAN Pain is a significant…
Lessons for more efficient research in healthcare settings
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…
Writing for good health
If you asked nurses how they reduce job stress, you probably wouldn’t expect them to reply, “By writing.” In fact, a recent…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic…
Shaving as a metaphor for nursing
Over the course of history, people have used metaphors to explain, contrive, reflect, and refute human phenomena. Health care (and all its…
FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell…
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.